Journal of Hepatology
Volume 54, Issue 1 , Pages 72-77 , January 2011

Sub-clinical hepatic encephalopathy in cirrhotic patients is not aggravated by sedation with propofol compared to midazolam: A randomized controlled study

  • Iyad Khamaysi

      Affiliations

    • Department of Gastroenterology, Rambam Medical Center, Haifa, Israel
    • ,
  • Nseir William

      Affiliations

    • Internal Medicine, Holy Family Hospital, Nazareth, Israel
    • ,
  • Alexandrov Olga

      Affiliations

    • Department of Anesthesia, Ziv Medical Centre, Safed, Israel
    • ,
  • Isakson Alex

      Affiliations

    • Department of Anesthesia, Ziv Medical Centre, Safed, Israel
    • ,
  • Mysh Vladimir

      Affiliations

    • Department of Gastroenterology, Ziv Medical Centre, Safed, Israel
    • ,
  • Dabbah Kamal

      Affiliations

    • Department of Gastroenterology, Ziv Medical Centre, Safed, Israel
    • ,
  • Assy Nimer

      Affiliations

    • Liver Unit, Ziv Medical Center, Safed, Israel
    • Technion Institute, Rappaport Faculty of Medicine, Haifa, Israel
    • Corresponding Author InformationCorresponding author at: Liver Unit, Ziv Medical Center, POB 1008, Safed 13100, Israel. Tel.: +972 4 682 8441/5; fax: +972 4 682 8442.

Received 3 March 2010 ,Revised 14 June 2010 ,Accepted 14 June 2010.

References 

  1. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th world congresses of gastroenterology, Vienna, 1998. Hepatology. 2002;35:716–721
  2. Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis. 2004;19:253–267
  3. Bajaj JS, Saeian K, Schubert CM, Hafeezullah M, Franco J, Varma RR, et al. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology. 2009;50:1175–1183
  4. Kircheis G, Knoche A, Hilger N, Manhart F, Schnitzler A, Schulze H, et al. Hepatic encephalopathy and fitness to drive. Gastroenterology. 2009;137:1706–1715
  5. Toubia N, Sanyal AJ. Portal hypertension and variceal hemorrhage. Med Clin N Am. 2008;92:551–574
  6. Jensen DM. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology. 2002;122:1620–1630
  7. Thuluvath PJ. Toward safer sedation in patients with cirrhosis: have we done enough?. Gastrointest Endosc. 2009;70:269–271
  8. McGuire BM. Safety of endoscopy in patients with end-stage liver disease. Gastrointest Endosc Clin N Am. 2001;11:111–130
  9. Delcò F, Tchambaz L, Schlienger R, Drewe J, Krähenbühl S. Dose adjustment in patients with liver disease. Drug Saf. 2005;28:529–545
  10. Neal EA, Meffin PJ, Gregory PB, Blaschke TF. Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis. Gastroenterology. 1979;77:96–102
  11. Steiner C, Sen S, Stange J, Williams R, Jalan R. Binding of bilirubin and bromosulphthalein to albumin: implications for understanding the pathophysiology of liver failure and its management. Liver Transpl. 2004;10:1531–1538
  12. Keefe EB. Sedation and analgesia for endoscopy. Gastroenterology. 1995;108:932–934
  13. American Society for Gastrointestinal Endoscopy (ASGE Standard of Practice Committee). Sedation and monitoring of patients undergoing gastrointestinal endoscopic procedures. Gastrointest Endosc 1995;42:626–629.
  14. American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology 2002;96:1004–1017.
  15. Tegeder I, Lötsch J, Geisslinger G. Pharmacokinetics of opioids in liver disease. Clin Pharmacokinet. 1999;37:17–40[review]
  16. Boulieu R, Lehmann B, Salord F, Fisher C, Morlet D. Pharmacokinetics of midazolam and its main metabolite 1-hydroxymidazolam in intensive care patients. Eur J Drug Metab Pharmacokinet. 1998;23:255–258
  17. Assy N, Rosser BG, Grahame GR, Minuk GY. Risk of sedation for upper GI endoscopy exacerbating subclinical hepatic encephalopathy in patients with cirrhosis. Gastrointest Endosc. 1999;49:690–694
  18. Mackenzie N, Grant IS. Propofol for intravenous sedation. Anaesthesia. 1987;42:3–6
  19. Morcos WE, Payne JP. The induction of anaesthesia with propofol compared in normal and renal failure patients. Postgrad Med J. 1985;61:62–63
  20. Servin F, Cockshott ID, Farinotti R, Haberer JP, Winckler C, Desmonts JM. Pharmacokinetics of propofol infusions in patients with cirrhosis. Br J Anaesth. 1990;65:177–183
  21. Weston BR, Chadalawada V, Chalasani N, Kwo P, Overley CA, Symms M, et al. Nurse-administered propofol versus midazolam and meperidine for upper endoscopy in cirrhotic patients. Am J Gastroenterol. 2003;98:2440–2447
  22. Kerker A, Hardt C, Schlief HE, Dumoulin FL. Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients. BMC Gastroenterol. 2010;10:11
  23. Riphaus A, Lechowicz I, Frenz MB, Wehrmann T. Propofol sedation for upper gastrointestinal endoscopy in patients with liver cirrhosis as an alternative to midazolam to avoid acute deterioration of minimal encephalopathy: a randomized, controlled study. Scand J Gastroenterol. 2009;44:1244–1251
  24. Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB. Validity and reliability of the observer’s assessment of alertness/sedation scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10:244–251
  25. Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34:768–773
  26. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40:922–935
  27. Smith MT, Eadie MJ, Brophy TOR. The pharmacokinetics of midazolam in man. Eur J Clin Pharmacol. 1981;19:271–278
  28. Rimmer KP, Graham K. Mechanism of hypoxemia during panendoscopy. J Clin Gastroenterol. 1989;11:17–22
  29. Vasudevan AE, Goh KL, Bulgiba AM. Impairment of psychomotor responses after conscious sedation in cirrhotic patients undergoing therapeutic upper GI endoscopy. Am J Gastroenterol. 2002;97:1717–1721
  30. Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol. 1986;3:75–82
  31. Rikkers L, Jenko P, Rudman D, Friedes D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology. 1978;75:462–469
  32. Gilberstadt SJ, Gilberstadt H, Zieve L, Buegel B, Collier RO, McClain CJ. Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med. 1980;140:519–521
  33. Schomerus H, Hamster W, Blunck H, Reinhard U, Mayer K, Dolle W. Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci. 1981;26:622–630
  34. O’Neill D. Physicians, elderly drivers and dementia. Lancet. 1992;41–43
  35. Dubinsky RM, Stein AC. Minimal hepatic encephalopathy and driving. Hepatology. 2009;50:1007–1008
  36. Dundee JW, Halliday NJ, Harper KW, Brogden RN. Midazolam, a review of its pharmacological and therapeutic use. Drugs. 1984;28:519–543
  37. Maggilchrist AJ, Birnie GG, Cook A, Scobie G, Murray T, Watkinson G, et al. Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis. Gut. 1986;27:19–95
  38. Nolent P, Laudenbach V. Sedation and analgesia in the paediatric intensive care unit. Ann Fr Anesth Reanim. 2008;27:623–632
  39. Davies ADM. The influence of age on trail making test performance. J Clin Psychol. 1968;24:96–98
  40. Young C, Knudsen N, Hilton A, Reves JG. Sedation in the intensive care unit. Crit Care Med. 2000;28:854–866
  41. Baig WW, Nagaraja MV, Varma M, Prabhu R. Platelet count to spleen diameter ratio for the diagnosis of esophageal varices: is it feasible?. Can J Gastroenterol. 2008;22:825–828

PII: S0168-8278(10)00713-0

doi: 10.1016/j.jhep.2010.06.023

Journal of Hepatology
Volume 54, Issue 1 , Pages 72-77 , January 2011

Article Tools

* Image Usage & Resolution